Champix generics’ attempt to launch early, challenged by 14 companies

After challenges have been made to the substance patent of the Pfizer’s antismoking treatment Champix, other 14 Korean companies participated in the attempt. Once they get successful in the challenge, Champix generics are expected to be launched 2 years earlier

According to the industry on the 28^th, after CorePharm Bio filed for a defensive confirmation trial for the scope of the Champix’s su...